LCFA's mission is the dramatic improvement in survivorship of lung cancer patients through the funding of transformative science, with the ultimate goal of curing the disease. To accomplish this, LCFA will work to raise both the funds and the national profile of lung cancer in order to substantially increase support of innovative and groundbreaking research efforts.
FDA Approves Tibsovo Plus Vidaza For Patients With Newly Diagnosed Acute Myeloid Leukemia
Surgery Timing May Have ‘Little Effect’ on Time to Ovarian Cancer Disease Progression
Will My Daughter Be a Triple-Positive Breast Cancer Pioneer?
Trial Will Investigate Drug Duo in Solid Cancers With MAPK Pathway Aberrations